Naradja Wissmar: Raised IL-32 as a Hint to Long-Term Immune Activation Post-COVID
Naradja Wissmar, Former Administrator at Karolinska Institute, shared on LinkedIn:
”University of Milan teams found SARS-CoV-2 exposure raised blood IL 32, an inflammatory cytokine, and levels stayed high at least 1 year after severe COVID 19, hinting at lingering immune activation and a biomarker for long term effects.”
Title: Association of SARS-CoV-2 infection with long-lasting increase in circulating IL-32 levels
Authors: Lorenzo Miano, Elena Sinopoli, Alessandro Cherubini, Chiara Suffritti, Serena Pelusi, Fatima Rahmeh, Giuseppe Enzo Lamorte, Flora Peyvandi, Francesco Blasi, Giacomo Grasselli, Alessandra Bandera, Roberta Gualtierotti, Daniele Prati, Luca Vittorio Carlo Valenti
Read the Full Article on Frontiers
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 17, 2026, 04:07Weihao Li: Global HEPATIC Registry Findings on Post-Transplant Arterial Thrombosis
-
Oct 17, 2026, 03:56Ghaith Abu-Zeinah: ASH Publishes 2026 Guidelines for Myelofibrosis Management in Blood Advances
-
Oct 17, 2026, 03:48Tristan Siokos: Why Vascular Occlusion Is More Than Just Clots – Breakdown of the 8 Pathways
-
Oct 17, 2026, 02:36Archil Jaliashvili: Oxygen Transport in Capillaries
-
Oct 17, 2026, 02:35Carly Newton: Understanding Access to Red Blood Cell Exchange for People Living With SCD
-
Oct 17, 2026, 02:34Raising Awareness of Blood Clots During and After Pregnancy – Thrombosis UK
-
Oct 17, 2026, 02:33Alaa Salamat: Our Research Accepted for Publication at ASH 2026
-
Oct 17, 2026, 02:32Mohammed Al Sharif: Discussing Factor XIII Testing and Its Clinical Significance
-
Oct 17, 2026, 02:31Joanna Popiolek-Kalisz: Talking about Novel Pharmacotherapy for Hypertension at CV Prevention and Intervention